← Back to Search

Procedure

Osprey IV for Vascular Access Complications

N/A
Waitlist Available
Led By Gerado Chiricolo, MD
Research Sponsored by Community Medical Center, Toms River, NJ
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Anticipated admission to inpatient unit
Be older than 18 years old
Must not have
Previous venous grafts or surgery at the target vessel access site
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial will involve patients in the Emergency Department receiving IV access through a specific catheter as part of routine care. The experiences of both patients and clinicians, including any negative effects, will be documented.

Who is the study for?
This trial is for Emergency Department patients who need an IV line placed as part of their routine care. There are no specific inclusion or exclusion criteria provided, so it appears open to any patient requiring IV access in the participating departments.
What is being tested?
The study is testing a new needle over catheter device called Osprey IV against historical controls, which means they'll compare its performance with past data on standard methods. They're looking at how well it works on the first try and if it reduces complications.
What are the potential side effects?
While specific side effects aren't listed, adverse events related to the use of the Osprey IV catheter will be recorded. This could include issues like pain at insertion site, infection, bruising or bleeding.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I expect to be admitted to the hospital soon.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had surgery or vein grafts on the vessel to be used for access.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Attempts
Secondary study objectives
Blood culture contamination rates
Drainage
Edema
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Osprey IVExperimental Treatment2 Interventions
Subjects enrolled will receive the study device as part of their routine medical care.

Find a Location

Who is running the clinical trial?

Community Medical Center, Toms River, NJLead Sponsor
5 Previous Clinical Trials
1,155 Total Patients Enrolled
Gerado Chiricolo, MDPrincipal InvestigatorRobert Wood Johnson Barnabas Health
~133 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top